Euler Biologics
PrivateLast Round
Seed
Sep 1, 2024
Company Overview
Euler Biologics is a biotechnology company developing antibody-based therapies designed to preserve and enhance physical function for older adults.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Euler Biologics Comparables
Compare Euler Biologics with similar companies based on industry and business-model similarity.
Euler Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 1, 2024 |
Euler Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Seed |
| Pillar VC | Seed |
| Soma Capital | Seed |
| Axial VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2024
Seed round raised from Gaingels, Pillar VC, Soma Capital, and Axial VC.
Euler Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Euler Biologics's valuation, stock price, and market status.